Human exposures to mutagens--an analysis using the genetic activity profile database. by Tice, R R et al.
Human Exposures to Mutagens-
An Analysis Using the Genetic
Activity Profile Database
R.R. Tice,' H.F. Stack,1 and M.D. Waters2
1lntegrated Laboratory Systems, Research Triangle Park, North Carolina;
2U.S. Environmental Protection Agency, Research Triangle Park,
North Carolina
The Genetic Activity Profile (GAP) database was used to identify and compare agents showing
genotoxic activity in humans. The database revealed several substances for which both human
and rodent cytogenetic data existed. Based on the ratio of the lowest effective doses (LEDs) in
rodent versus human studies, humans appear to be at least 10 times more sensitive than rodents
to the majority of the genotoxic substances examined. Several caveats are discussed which may
be responsible, in part, for the apparent differences in sensitivity. Some of these differences
could be due to variations in the test protocols or they may, in fact, reflect real differences
between human and rodent cells. However, in contrast to the in vivo comparison, the LEDs for
human data from in vitro studies were not uniformly lower than for comparable studies in
rodents. The in vitro comparison suggests that the apparent differences in human versus rodent
cell sensitivity seen in vivo must be viewed with a degree of caution. Nevertheless, the overall
GAPs for these agents, and particularly the human in vivo data, underscore the concern for
adequate protection of humans exposed to these environmental mutagens. Environ Health
Perspect 104(Suppl 3):585-589 (1996)
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For more than 10 years, the U.S.
Environmental Protection Agency (U.S.
EPA) and the International Agency for
Research on Cancer (IARC) have collabo-
rated in the development ofan interna-
tional database on the genetic and related
effects of presumptive carcinogens to
which humans are exposed. The U.S.
EPA/IARC Genetic Activity Profile (GAP)
database is a stand-alone personal com-
puter software package for presentation of
genetic toxicology data in both graphic and
text formats. This database is available
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from the authors (M.D.Waters) and pro-
vides quantitative dose and effect informa-
tion that is useful in guiding the selection
ofhuman biomonitoring techniques for
field applications and laboratory-based
investigations on agents ofconcern.
A comprehensive discussion of the
GAP methodology is presented in Waters
et al. (1,2). Briefly, graphic activity profiles
are bar graphs with lines representing tests
and identified by three-letter codes that
are organized along the x-axis in either a
phylogenetic or end point sequence (Figure
1). Values plotted on the y-axis are a loga-
rithmic transformation ofthe lowest effec-
tive doses (LED) or highest ineffective
doses (HID) reported in the literature.
Positive test results extend vertically above
the baseline to the mean LED while nega-
tive test results extend below the baseline
to the mean HID. Dashed vertical lines
represent a minority call for conflicting
studies, and the lines extend-to the extreme
LED or HID. All data are original quan-
titative results abstracted from the pub-
lished literature. The current database
contains short-term test results on 565
agents evaluated by IARC and U.S. EPA,
the latter including priority chemicals
found at Superfund waste sites, pesticides,
and hazardous air pollutants. A complete
data record in GAP provides the chemical
name, Chemical Abstracts Service registry
number, a test code, test end point, quali-
tative test result, HID or LED, reference
number, and a short citation. An example
GAP based on phylogeny is presented in
Figure 2 for ethylene oxide, an IARC
Group 1 carcinogen (3) that has been
demonstrated to induce genetic damage in
occupationally exposed humans.
In constructing a GAP, doses derived
from human studies are converted to
milligrams per kilogram body weight (bw)
per day ofexposure using standard inhala-
tion rates, body surface area, and body
weightvalues for each sex. Certain assump-
tions were made because of the physical
properties of compounds and routes of
exposure (e.g., from inhalation ofparti-
cles). Variation occurs in particle size of
specific compounds and the rate ofdeposi-
tion in different areas ofthe respiratory
system; however, 100% absorption was
generally assumed. When reported, the
dose at the target site was used. For exam-
ple, in a study on lead exposure, the dose
extracted was the measured blood level
concentration in micrograms per milliliter.
Similarly, doses obtained from in vivo
mammalian tests were converted to mil-
ligram per kilogram bw per day ofexpo-
sure, assuming 100% absorption and using
standard weight and intake values for each
sex and species ofrodent, as reported by
Gold et al. (4). For example, in a test using
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Figure 1. A schematic diagram of a genetic activity
profile showing four studies for the test ECW (2 posi-
tive and 2 negative). The mean log dose unit of the
majority call is indicated by a solid vertical bar. A
dashed vertical bar indicates conflicting test results
among the studies. Note, in cases where the number
of positive and negative studies are the same, as illus-
trated here, the call is assigned positive.
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Figure 2. A is the genetic activity profile of ethylene oxide with tests organized phylogenetically. B shows the
details of the in vivo mammalian tests for ethylene oxide. Bone marrow (CBA) and lymphocyte (CLA and CLH) tests
are highlighted.
male mice fed 50 ppm of an agent in the
diet, the standard food intake per day is
12% ofthe bodyweight, and the conversion
is dose = 50 ppm x 12% =6 mg/kg bw/day.
The multitest information in the GAP
database has proved useful for the compar-
ative assessment of both qualitative and
quantitative results across several dimen-
sions [e.g., concordance across species and
end points (1), test battery selection (5),
evaluation of relative potencies of agents
(6), assessment of chemical structure-
activity relationships (7), and evaluation
of the activity of mixtures of chemicals
(8)]. Here, the GAP database was used to
identify and compare agents showing
genotoxic activity in humans exposed to
environmental mutagens.
The GAP database was searched to
identify data resulting from in vivo human
exposures and 41 substances were found
(Table 1). Thirty-four of these substances
had been evaluated for their ability to
induce chromosomal damage in peripheral
blood lymphocytes sampled from exposed
individuals, while data on the remaining
seven substances involved an assessment of
other genotoxic end points, primarily sis-
ter chromatid exchanges. The mean LEDs
or HIDs for chromosomal aberrations in
human lymphocytes are provided in
Figure 3 for the 34 substances, identified
by exposure type and ordered by the mag-
nitude of the exposure. Among the 21
substances that induced chromosomal
damage, 12 involved occupational and/or
environmental exposures and 9 involved
medical treatments. Phosphine was the
most potent substance in terms of dose
(indicated by the height of the bar) while
paracetamol was the least active in inducing
genotoxic damage in humans.
It was of interest to compare the rela-
tive potency ofthese agents in humans to
rodent systems. An analysis ofthe database
resulted in 15 substances (8 occupational/
environmental and 7 medical) for which
both human and rodent cytogenetic data
existed. Five animal studies involved the
use ofblood lymphocytes while 14 studies
involved bone marrow cells (Figure 4).
Based on the ratio ofLEDs in rodent ver-
sus human studies, humans appear to be at
least 10 times more sensitive than rodents
to the majority ofthe genotoxic substances
examined. Several caveats are involved in
this comparison that may be responsible,
in part, for the apparent difference in sen-
sitivity. These include, for example, differ-
ences in the route ofexposure (inhalation
or oral in humans, intraperitoneal or oral
in rodents) and in the type of exposure
(predominantly chronic for humans, acute
for animals).
To determine whether this differential
sensitivity is also found for these sub-
stances when tested in vitro, seven sub-
stances were identified with both human
and animal cell clastogenicity data (Figure
5). Again, the human data were limited to
blood lymphocytes while the animal data
were limited to transformed cells in cul-
ture, predominantly Chinese hamster
ovary and Chinese hamster lung cell lines.
In contrast to the in vivo comparison, the
LEDs for human data were not uniformly
lower than for rodents. Using a 10-fold
difference in mean LED as an indicator of
a significant difference in sensitivity,
rodent cells appeared to be more sensitive
to mercuric compounds while human
cells appeared to be more sensitive to epi-
chlorohydrin and myleran. Human and
rodent cells appeared to be equally sensi-
tive to thiotepa, bleomycin, and cyclo-
phosphamide. Some of the apparent
differences in sensitivity could be due to
differences in cell type or protocol design
or they may in fact reflect an intrinsic dif-
ference between human and rodent cells.
The in vitro comparison suggests that the
apparent differences in human versus
rodent cell sensitivity seen in vivo (Figure
4) must be viewed with a degree of cau-
tion. However, the overall GAPs for these
agents, and particularly the human in vivo
data, should cause increased concern for
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Table 1. Matrix of test resultsafor 41 compounds in the U.S. EPA/IARC GAP database.
Agents CASRN Exposure SLH SVH CBH CLH AVH
Acrylonitrile 107-13-1 Occup/Envir
Azathioprine 446-86-6 Therapy - ? +
Bleomycin 11056-06-7 Therapy + INEM~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Chloroethylcyclohexylnitrosourea 13010474 Therapy +
Chloroprene 126-99-8 Occup/Envir +
Cyclamate, sodium 139-05-9 Food
Cyclosporin A 59865-13-3 Therapy +
Dacarbazine 4342-03-4 Therapy
Epichlorohydrin 106-89-8 Occup/Envir +
5-Fluorouracil 51-21-8 Therapy -
Isoniazide 54-85-3 Therapy
Melphalan 148-82-3 Therapy + +
Mercuric compounds 7439-97-6 Occup/Envir + + +
Metronidazole 443-48-1 Therapy
Nickel 7440-02-0 Occup/Envir + +
Pentachlorophenol 87-86-5 Occup/Envir - +
Phenytoin 57-41-0 Therapy + - -
Styrene 100-42-5 Occup/Envir -
Tetrachloroethylene 127-18-4 Occup/Envir
Toluene 108-88-3 Occup/Envir -
Xylenes 1330-20-7 Occup/Envir
Abbreviations: CASRN, Chemical Abstracts Service Registry number; AVH, aneuploidy in human cells in vivo; CBH, chromosomal aberrations in human bone marrow cells in
vivo; CLH, chromosomal aberrations in human lymphocytes in vivo; SLH, sister chromatid exchange in human lymphocytes in vivo; SVH, sister chromatid exchange in human
cells in vivo;Occup/Envir, occupational/environmental. 'Test results: +, positive; -, negative; ?, conflicting (1 positive and 1 negative).
adequate protection in humans exposed to
these substances.
As demonstrated by this brief report,
the current GAP database contains data on
a wide range of end points used to assess
genotoxic damage in humans exposed to
occupational and environmental agents.
While it contains information on several
end points (e.g., sister chromatid exchange
and DNA and protein binding) that are
useful in monitoring human exposure, the
GAP database does not contain informa-
tion on newer methods such as 32P-postla-
beling for DNA adducts and the use ofthe
single cell gel or comet assay to monitor
for DNA single-strand breaks or alkali-
labile damage. In view ofthe large number
of studies conducted using these tech-
niques, it is anticipated that the GAP data-
base will be modified in the near future to
incorporate this additional information.
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Figure 3. Rank order of agents based on mean doses (either the LED or HID) in the chromosomal aberration test following human
exposure. Abbreviations: DDT, 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane; 2,4-D, dichlorophenoxyacetic acid; 2,3,7,8-TCDD,
2,3,7,8-tetrachlorodibenzo-p-dioxin; Occup/Envir, occupational/environmental. The effective doses are grouped by the type of
exposure, andthe ineffective doses are mixed exposure types.
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Figure 4. Ratio of mean LEDs from in vivo studies of chromosomal aberrations in animal bone marrow (CBA) and lymphocytes
ICLA) relative to aberrations in human lymphocytes(CLH). Occup/Envir, occupational/environmental. A ratio greater than 1 indicates
that the mean effective dose in human studies is a more sensitive indicator of genotoxicity for the chemical than the mean LED in
the comparable animal studies. Conversely, values less than 1 indicate the animal tests are more sensitive than the human tests.
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Figure 5. Ratios (CIC/CHL) of mean LEDs from in vitro studies of chromosomal aberrations in Chinese hamster
cells(CIC) relative to aberrations in human lymphocytes(CHL). A ratio greaterthan 1 indicatesthatthe mean effec-
tive dose in human cells is a more sensitive indicator of genotoxicity for the chemical than the mean LED in the
comparable animal cells. In vivodata(CBA/CLH)from Figure 4are repeated hereforcomparison.
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